Literature DB >> 28240687

Liberal Versus Restrictive Transfusion Strategy in Critically Ill Oncologic Patients: The Transfusion Requirements in Critically Ill Oncologic Patients Randomized Controlled Trial.

Fabricio S Bergamin1, Juliano P Almeida, Giovanni Landoni, Filomena R B G Galas, Julia T Fukushima, Evgeny Fominskiy, Clarice H L Park, Eduardo A Osawa, Maria P E Diz, Gisele Q Oliveira, Rafael A Franco, Rosana E Nakamura, Elisangela M Almeida, Edson Abdala, Maristela P Freire, Roberto K Filho, Jose Otavio C Auler, Ludhmila A Hajjar.   

Abstract

OBJECTIVE: To assess whether a restrictive strategy of RBC transfusion reduces 28-day mortality when compared with a liberal strategy in cancer patients with septic shock.
DESIGN: Single center, randomized, double-blind controlled trial.
SETTING: Teaching hospital. PATIENTS: Adult cancer patients with septic shock in the first 6 hours of ICU admission.
INTERVENTIONS: Patients were randomized to the liberal (hemoglobin threshold, < 9 g/dL) or to the restrictive strategy (hemoglobin threshold, < 7 g/dL) of RBC transfusion during ICU stay.
MEASUREMENTS AND MAIN RESULTS: Patients were randomized to the liberal (n = 149) or to the restrictive transfusion strategy (n = 151) group. Patients in the liberal group received more RBC units than patients in the restrictive group (1 [0-3] vs 0 [0-2] unit; p < 0.001). At 28 days after randomization, mortality rate in the liberal group (primary endpoint of the study) was 45% (67 patients) versus 56% (84 patients) in the restrictive group (hazard ratio, 0.74; 95% CI, 0.53-1.04; p = 0.08) with no differences in ICU and hospital length of stay. At 90 days after randomization, mortality rate in the liberal group was lower (59% vs 70%) than in the restrictive group (hazard ratio, 0.72; 95% CI, 0.53-0.97; p = 0.03).
CONCLUSIONS: We observed a survival trend favoring a liberal transfusion strategy in patients with septic shock when compared with the restrictive strategy. These results went in the opposite direction of the a priori hypothesis and of other trials in the field and need to be confirmed.

Entities:  

Mesh:

Year:  2017        PMID: 28240687     DOI: 10.1097/CCM.0000000000002283

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

1.  [Intensive care studies from 2017/2018].

Authors:  C J Reuß; M Bernhard; C Beynon; A Hecker; C Jungk; C Nusshag; M A Weigand; D Michalski; T Brenner
Journal:  Anaesthesist       Date:  2018-09       Impact factor: 1.041

Review 2.  [Evidence-based interdisciplinary treatment of abdominal sepsis].

Authors:  T Schmoch; M Al-Saeedi; A Hecker; D C Richter; T Brenner; T Hackert; M A Weigand
Journal:  Chirurg       Date:  2019-05       Impact factor: 0.955

Review 3.  RBC Transfusion Triggers: Is There Anything New?

Authors:  Tina Tomic Mahecic; Martin Dünser; Jens Meier
Journal:  Transfus Med Hemother       Date:  2020-09-24       Impact factor: 3.747

4.  The sicker the patient, the more likely that transfusion will be beneficial.

Authors:  Jean-Louis Vincent; Christophe Lelubre
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

5.  Transfusion thresholds: the dangers of guidelines based on randomized controlled trials.

Authors:  Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2020-01-07       Impact factor: 17.440

6.  The Decision to Transfuse: One Size Might Not Fit All.

Authors:  Christopher Stowell; Elliott Bennett-Guerrero
Journal:  Crit Care Med       Date:  2017-05       Impact factor: 7.598

7.  Lifetime Transfusion Burden and Transfusion-Related Iron Overload in Adult Survivors of Solid Malignancies.

Authors:  F J Sherida H Woei-A-Jin; Shu Zhen Zheng; Inci Kiliçsoy; Francisca Hudig; Saskia A C Luelmo; Judith R Kroep; Hildo J Lamb; Susanne Osanto
Journal:  Oncologist       Date:  2019-08-27

8.  Recommendations on RBC Transfusion Support in Children With Hematologic and Oncologic Diagnoses From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Marie E Steiner; Nicole D Zantek; Simon J Stanworth; Robert I Parker; Stacey L Valentine; Leslie E Lehmann; Cassandra D Josephson; Scot T Bateman; Naomi L C Luban
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

Review 9.  Fluid Management in Sepsis.

Authors:  Ryan M Brown; Matthew W Semler
Journal:  J Intensive Care Med       Date:  2018-07-09       Impact factor: 3.510

Review 10.  Liberal Transfusion versus Restrictive Transfusion and Outcomes in Critically Ill Adults: A Meta-Analysis.

Authors:  Wei Zhang; Yan Zheng; Kun Yu; Juan Gu
Journal:  Transfus Med Hemother       Date:  2020-03-20       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.